Scientists test supercharged immune cells to fight tough skin cancer
NCT ID NCT05869539
Summary
This is an early safety study for people with advanced melanoma that has stopped responding to standard treatments. Doctors will collect a patient's own tumor-fighting immune cells, grow them in a lab, and then infuse them back into the patient along with a new drug (ANV419) designed to help those cells expand and work better inside the body. The main goal is to see if this combined treatment is safe and tolerable for up to 10 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Basel
Basel, Basel, 4031, Switzerland
Conditions
Explore the condition pages connected to this study.